
Ritivel YCアプリケーション
RitivelはWinter 2026バッチでHealthcare企業としてY Combinatorを卒業しました。以下:会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。
- YCバッチ
- Winter 2026
- 業界
- HealthcareHealthcare IT
- チーム規模
- 3
- ステータス
- Active
- ローンチ済み
- 2026
創業者
Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder
Ritivelの事業内容
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.
RitivelのYCアプリケーション、再構築済み
Y Combinator 申請
Ritivel 様、Winter 2026 バッチ。公開データから回答された、実際のフォームの質問。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Ritivel
AI-native platform for Life-Sciences Documentation
We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.
We live in San Francisco and plan to keep the company based here after YC as well.
San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.
よくある質問
Ritivelの実際のYCアプリケーションですか?
いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、Ritivelの公開データ(ローンチノート、創業者経歴、製品説明)から回答しています。Ritivelのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。
RitivelはどのYCバッチに参加しましたか?
RitivelはY CombinatorのWinter 2026バッチに参加しました。
Ritivelは誰によって設立されましたか?
RitivelはNirmit Arora, Gunin Gupta, Pavan Kalyan (a.k.a PK) Tankalaによって設立されました。
Ritivelは何をしていますか?
AI-native platform for Life-Sciences Documentation
完全な再構築されたアプリケーションはどのように読めばよいですか?
無料のRound Fundedアカウントを作成してください。 Ritivelの26つの回答からなる完全なアプリケーションと、他のすべてのYCバッチはYC Insightsにあります。